We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-11.77%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$206M
AUM Growth
+$13.8M
Cap. Flow
+$393M
Cap. Flow %
191%
Top 10 Hldgs %
54.28%
Holding
94
New
23
Increased
21
Reduced
13
Closed
30

Top Buys

1
NEOS
Neos Therapeutics, Inc
NEOS
+$20M
2
FDX icon
FedEx
FDX
+$8M
3
BERY
Berry Global Group, Inc.
BERY
+$7.06M
4
SWFT
Swift Transportation Company
SWFT
+$5.26M
5
PRAA icon
PRA Group
PRAA
+$5.22M

Top Sells

1
MCK icon
McKesson
MCK
+$11.5M
2
SCI icon
Service Corp International
SCI
+$6.47M
3
MRK icon
Merck
MRK
+$3.64M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$2.81M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.67M

Sector Composition

1 Healthcare 56.15%
2 Industrials 14.14%
3 Financials 9.65%
4 Technology 4.03%
5 Materials 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$136B
$21M 10.21%
217,919
+919
+0.4% +$96.6K
NEOS
2
DELISTED
Neos Therapeutics, Inc
NEOS
$17.2M 8.33%
+907,358
New +$20M
CAH icon
3
Cardinal Health
CAH
$53.6B
$13.8M 6.72%
180,218
+218
+0.1% +$18.2K
RRTS
4
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$13.1M 6.37%
28,533
– –
ZVRA icon
5
Zevra Therapeutics
ZVRA
$754M
$12.1M 5.88%
39,056
+5,016
+15% +$1.54M
FOMX
6
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$7.33M 3.56%
1,000,000
+15,266
+2% +$156K
FDX icon
7
FedEx
FDX
$75.9B
$7.22M 3.5%
+50,141
New +$8M
SPY icon
8
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$6.93M 3.37%
3,000,000
+1,600,000
+114% +$325M
BERY
9
DELISTED
Berry Global Group, Inc.
BERY
$6.76M 3.28%
+244,836
New +$7.06M
ELV icon
10
Elevance Health
ELV
$80.9B
$6.32M 3.07%
45,118
+118
+0.3% +$17.7K
PFNX
11
DELISTED
Pfenex Inc.
PFNX
$6.02M 2.92%
400,901
+19,082
+5% +$388K
HCA icon
12
HCA Healthcare
HCA
$85.6B
$5.87M 2.85%
75,874
+874
+1% +$77.4K
MFIC icon
13
MidCap Financial Investment
MFIC
$821M
$5.34M 2.59%
325,000
– –
PRAA icon
14
PRA Group
PRAA
$702M
$4.76M 2.31%
+90,000
New +$5.22M
APO icon
15
Apollo Global Management
APO
$71.1B
$4.43M 2.15%
258,119
+8,119
+3% +$162K
NSTG
16
DELISTED
NanoString Technologies, Inc.
NSTG
$4.07M 1.98%
254,505
+137,369
+117% +$2.15M
BKD icon
17
Brookdale Senior Living
BKD
$3.65B
$4.02M 1.95%
+175,000
New +$5.17M
DVAX
18
DELISTED
Dynavax Technologies
DVAX
$3.8M 1.85%
155,000
+55,000
+55% +$1.56M
SWFT
19
DELISTED
Swift Transportation Company
SWFT
$3.75M 1.82%
+250,000
New +$5.26M
GS icon
20
Goldman Sachs
GS
$323B
$3.52M 1.71%
+20,232
New +$3.97M
AAPL icon
21
Apple
AAPL
$4.89T
$3.36M 1.63%
121,724
+97,852
+410% +$2.87M
ACAD icon
22
Acadia Pharmaceuticals
ACAD
$4.39B
$2.98M 1.44%
90,000
+25,000
+38% +$1.04M
SUN icon
23
Sunoco
SUN
$13.6B
$2.54M 1.23%
+75,000
New +$2.87M
AMGN icon
24
Amgen
AMGN
$201B
$2.12M 1.03%
15,321
+321
+2% +$50.6K
URI icon
25
United Rentals
URI
$67.1B
$2.1M 1.02%
+35,000
New +$2.43M
1
2 3 4

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, DSC Advisors held 94 positions worth $206M, up 7.2% from $192M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

DSC Advisors deployed $393M of net new capital in Q3 2015, opening 23 new positions and adding to 21 existing holdings. Its largest new stake was Neos Therapeutics, Inc: 907,358 shares worth $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 62% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Alkermes, an estimated $1.48M trimmed.

  • DSC Advisors's largest Q3 2015 buy was Neos Therapeutics, Inc: 907,358 shares worth $17.2M.
  • DSC Advisors added most to Apple in Q3 2015, an estimated $2.87M increase.
  • DSC Advisors's biggest Q3 2015 reduction was Alkermes, cutting an estimated $1.48M.
  • DSC Advisors fully exited McKesson in Q3 2015, selling an estimated $11.5M.
  • DSC Advisors's ten largest holdings make up 54% of its $206M portfolio in Q3 2015.
  • DSC Advisors opened 23 new positions and closed 30 in Q3 2015.
  • DSC Advisors's portfolio value rose 7.2% quarter-over-quarter to $206M.

Based on DSC Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.